Being a first-time founder has its blessings and its courses. During this session, we want to talk about the realistic goals of embarking on the exciting and challenging journey of starting your first business. Especially if you have been working in academia for the past years and you want right now to make the leap and start your own company based on your research results, you will have a better experience starting a spinout if you are armed with some expectations about your likely journey. Spinning-off requires a clear time and usually also money commitment, and its success highly depends on the founder team’s passion, irrational optimism and deep faith in the technology they’ve developed. From writing their first business plan to their first investment and scaling up, 3 founders from 3 different TU Wien-affiliated companies in different stages share their experience with transforming their research into successful products or services.
– have a good overview of what obstacles to avoid when founding a university spin-out
– have gained some insights on how to structure your next steps
Nermina Mumic, Founder & CEO of Legitary
Nermina Mumic is CEO & founder of Legitary, an award winning tech-startup powering the monetization of music rights. Legitary’s patented AI powered soft audit technology verifies streaming royalties and forecasts future music catalogue revenues.
Nermina has a background as data scientist, she graduated from Vienna University of Technology with a master’s degree in Technical Mathematics. As part of her PhD in Statistics she developed and patented the Legitary algorithm. Nermina is listed as Forbes 30u30 and global shaper at WEF.
Check Nermina Mumic on Linkedin
Elizabeth Pavez Lorie, Co-Founder & CEO of CompreVie
Elizabeth is a globally-minded scholar with a PhD in medical sciences, complemented by master’s and engineering degrees from Sweden. With over two decades of expertise in human in vitro modeling and drug development, she’s notably contributed to treating rare skin diseases and pioneering microRNA mapping and worked for a better understanding of the environment’s impact on human biology and disease.
As
a passionate advocate for student and PostDoc rights, work-life balance, and workplace equity in Europe, Elizabeth is also deeply engaged in popular science initiatives. Her entrepreneurial journey began in childhood when she sought a cure for her father’s
chronic illness. After a PostDoc and junior positions in Germany, she reached Vienna where she co-founded CompreVie, an in vitro diagnostic company, with Ifigeneia and Christian. Together, they aim to reshape drug development for enhanced efficiency and precision,
reflecting Elizabeth’s commitment to scientific innovation
Check Elizabeth Pavez Lorie on Linkedin
Gregor Weisgrab, MSc, Co-Founder & CEO at Biomotion Technologies
Gregor Weisgrab is the CEO and Co-founder of Biomotion Technologies, a startup developing 3D Bioprinters, that enable tissue engineering companies to reliably and reproducibly scale their fabrication of human tissue implants.
Gregor Weisgrab previously did his PhD at TU Wien at the material science department, where he worked on machines that automate the production of human bone and cartilage units (spheroids). Before that, he did a joint masters degree between University Utrecht and University of Wollongong in Biofabrication, working on 3D-printed microfluidics for cartilage tissue and collagen-based drug delivery vehicles for the cornea.
Check Gregor Weisgrab on Linkedin
The Entrepreneurship for Scientists Series organized by the TU Wien Innovation Incubation Center (i²c) is targeting scientists who would like to enrich or develop a personal entrepreneurial skillset & business competencies, know more about opportunities how to navigate innovations from „the lab“ to society or who would simply like to engage in entrepreneurial thinking. These workshops are free of charge to scientists from all faculties and institutes of TU Wien. Registration required.
_______________________________________________________________________________________
